These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26593157)

  • 1. A Chemical Inhibitor of the Skp2/p300 Interaction that Promotes p53-Mediated Apoptosis.
    Oh M; Lee JH; Moon H; Hyun YJ; Lim HS
    Angew Chem Int Ed Engl; 2016 Jan; 55(2):602-6. PubMed ID: 26593157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2 Inhibitors: Novel Anticancer Strategies.
    Lee Y; Lim HS
    Curr Med Chem; 2016; 23(22):2363-79. PubMed ID: 27160538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
    Kitagawa M; Lee SH; McCormick F
    Mol Cell; 2008 Feb; 29(2):217-31. PubMed ID: 18243116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deathproof: new insights on the role of skp2 in tumorigenesis.
    Reed SI
    Cancer Cell; 2008 Feb; 13(2):88-9. PubMed ID: 18242509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
    Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
    Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening for inhibitors of the Cks1-Skp2 interaction.
    Huang KS; Vassilev LT
    Methods Enzymol; 2005; 399():717-28. PubMed ID: 16338391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin remodelling protein SMAR1 inhibits p53 dependent transactivation by regulating acetyl transferase p300.
    Sinha S; Malonia SK; Mittal SP; Mathai J; Pal JK; Chattopadhyay S
    Int J Biochem Cell Biol; 2012 Jan; 44(1):46-52. PubMed ID: 22074660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2.
    Wang Z; Inuzuka H; Zhong J; Liu P; Sarkar FH; Sun Y; Wei W
    Oncotarget; 2012 Nov; 3(11):1294-300. PubMed ID: 23230084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation-dependent regulation of Skp2 function.
    Inuzuka H; Gao D; Finley LW; Yang W; Wan L; Fukushima H; Chin YR; Zhai B; Shaik S; Lau AW; Wang Z; Gygi SP; Nakayama K; Teruya-Feldstein J; Toker A; Haigis MC; Pandolfi PP; Wei W
    Cell; 2012 Jul; 150(1):179-93. PubMed ID: 22770219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The WTX tumor suppressor enhances p53 acetylation by CBP/p300.
    Kim WJ; Rivera MN; Coffman EJ; Haber DA
    Mol Cell; 2012 Mar; 45(5):587-97. PubMed ID: 22285752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.
    Chan CH; Morrow JK; Li CF; Gao Y; Jin G; Moten A; Stagg LJ; Ladbury JE; Cai Z; Xu D; Logothetis CJ; Hung MC; Zhang S; Lin HK
    Cell; 2013 Aug; 154(3):556-68. PubMed ID: 23911321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skp2B attenuates p53 function by inhibiting prohibitin.
    Chander H; Halpern M; Resnick-Silverman L; Manfredi JJ; Germain D
    EMBO Rep; 2010 Mar; 11(3):220-5. PubMed ID: 20134482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis.
    Zhao H; Wang H; Bauzon F; Lu Z; Fu H; Cui J; Zhu L
    J Biol Chem; 2016 May; 291(19):10201-9. PubMed ID: 26966181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer.
    Rezaeian AH; Phan LM; Zhou X; Wei W; Inuzuka H
    Neoplasia; 2023 Apr; 38():100890. PubMed ID: 36871351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
    Zhu Q; Wani G; Wani MA; Wani AA
    Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
    Bornstein G; Ganoth D; Hershko A
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
    Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.